Delivery Order SPE2DB20D3103-SPE2DB23FL6F0
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,659.58 firm fixed-price delivery order is for the supply of 88 ml vials of 50 mg/ml valganciclovir HCl, a medication used to prevent and treat cytomegalovirus infections. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,012.82 firm fixed-price delivery order is for the supply of 88 ml vials of 50 mg/ml valganciclovir hydrochloride, a medication used to prevent cytomegalovirus (CMV) infection in transplant recipients. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,907.97, is for the delivery of Valganciclovir 450 mg tablets. It is a firm fixed-price delivery order contract with a completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of 60 tablets of 450 mg Valganciclovir, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,186.10 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 9, 2024 and was awarded on August 8, 2024. This delivery order appears to be part of a larger Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 tablets of 450 mg Valganciclovir, a prescription medication. The firm fixed-price delivery order has a ceiling value of $1,633.96 and a completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is a delivery order (SPE2DB22D3004|SPE2DB25FPH63) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,055.37 firm fixed-price contract is for the supply of valganciclovir HCL 50 mg/ml, an antiviral medication, to support military healthcare programs. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,158,577 units of Valganciclovir 450 mg tablets in 60-count packages, with a ceiling value of $3,526.68. It is a firm fixed-price delivery order contract with a performance period ending on May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of the medication Valganciclovir 450 mg tablets, with a ceiling value of $2,585.74 and a completion date of July 7, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,334.51, is for the delivery of 4566708387 units of the medication valganciclovir 450 mg tablets. The contract is a firm fixed-price delivery order, with a completion date of December 13, 2024. The contract was not designated as a set-aside. AmerisourceBergen holds a significant...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 19, 2025, for the supply of Valganciclovir 450 mg tablets in unit dose packages of 20 tablets. This is a firm fixed-price contract valued at $7,046.46, with an ultimate completion date of September 22, 2025. The contract carries no set-aside designation and represents a competitive award. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FL6F0Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,941.22 Firm Fixed Price delivery order is for the supply of 60 tablets of 450 mg Valganciclovir, a medication used to treat cytomegalovirus infections. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, which runs through November 2026, covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract award does not have a set-aside designation, indicating open competition. No subcontractors were mentioned in the provided information.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 11/15/22 |